Oppenheimer & Co. Inc. Acquires 93 Shares of Waters Co. (NYSE:WAT)

Oppenheimer & Co. Inc. lifted its holdings in Waters Co. (NYSE:WATFree Report) by 2.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 4,508 shares of the medical instruments supplier’s stock after buying an additional 93 shares during the period. Oppenheimer & Co. Inc.’s holdings in Waters were worth $1,484,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in WAT. Tower Research Capital LLC TRC increased its position in Waters by 223.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 8,222 shares of the medical instruments supplier’s stock valued at $2,707,000 after buying an additional 5,683 shares in the last quarter. NEOS Investment Management LLC bought a new stake in Waters in the 4th quarter valued at about $276,000. The Manufacturers Life Insurance Company increased its position in Waters by 3.4% in the 4th quarter. The Manufacturers Life Insurance Company now owns 83,200 shares of the medical instruments supplier’s stock valued at $27,394,000 after buying an additional 2,723 shares in the last quarter. California State Teachers Retirement System increased its position in Waters by 1.5% in the 4th quarter. California State Teachers Retirement System now owns 93,594 shares of the medical instruments supplier’s stock valued at $30,814,000 after buying an additional 1,356 shares in the last quarter. Finally, Madison Asset Management LLC increased its position in Waters by 27.1% in the 4th quarter. Madison Asset Management LLC now owns 187,483 shares of the medical instruments supplier’s stock valued at $61,725,000 after buying an additional 39,954 shares in the last quarter. 94.01% of the stock is owned by institutional investors.

Waters Price Performance

Shares of NYSE WAT opened at $301.47 on Tuesday. Waters Co. has a twelve month low of $231.90 and a twelve month high of $367.21. The stock’s 50 day moving average price is $326.71 and its 200-day moving average price is $323.52. The company has a market capitalization of $17.88 billion, a PE ratio of 29.58, a PEG ratio of 4.81 and a beta of 0.97. The company has a quick ratio of 1.30, a current ratio of 1.94 and a debt-to-equity ratio of 1.60.

Waters (NYSE:WATGet Free Report) last announced its earnings results on Tuesday, May 7th. The medical instruments supplier reported $2.21 earnings per share for the quarter, topping analysts’ consensus estimates of $2.10 by $0.11. Waters had a return on equity of 66.59% and a net margin of 20.75%. The firm had revenue of $636.80 million for the quarter, compared to the consensus estimate of $635.57 million. During the same quarter in the previous year, the business earned $2.49 EPS. The company’s revenue was down 7.0% compared to the same quarter last year. On average, equities analysts anticipate that Waters Co. will post 11.85 EPS for the current year.

Insider Transactions at Waters

In other news, Director Richard H. Fearon acquired 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The shares were acquired at an average price of $332.90 per share, for a total transaction of $332,900.00. Following the completion of the purchase, the director now owns 1,653 shares in the company, valued at $550,283.70. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Christopher A. Kuebler sold 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $361.64, for a total value of $1,446,560.00. Following the transaction, the director now owns 14,716 shares in the company, valued at $5,321,894.24. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Richard H. Fearon acquired 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The stock was purchased at an average price of $332.90 per share, for a total transaction of $332,900.00. Following the purchase, the director now owns 1,653 shares of the company’s stock, valued at approximately $550,283.70. The disclosure for this purchase can be found here. Company insiders own 0.82% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Stifel Nicolaus boosted their target price on Waters from $330.00 to $332.00 and gave the company a “hold” rating in a research report on Wednesday, May 8th. Jefferies Financial Group initiated coverage on Waters in a research note on Monday, June 3rd. They set a “hold” rating and a $320.00 price target for the company. Barclays cut their price target on Waters from $300.00 to $295.00 and set an “underweight” rating for the company in a research note on Wednesday, May 8th. Evercore ISI lifted their price target on Waters from $320.00 to $340.00 and gave the company an “in-line” rating in a research note on Thursday, April 4th. Finally, Robert W. Baird cut their price target on Waters from $319.00 to $312.00 and set a “neutral” rating for the company in a research note on Wednesday, May 8th. One investment analyst has rated the stock with a sell rating and eleven have assigned a hold rating to the company’s stock. According to MarketBeat.com, Waters currently has a consensus rating of “Hold” and an average price target of $307.20.

Check Out Our Latest Research Report on WAT

About Waters

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

See Also

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.